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aP2 Pparg2 Vstm2a * * C t r l P P A R γ 2 C t r l P P A R γ 2 C t r l P P A R γ 2 C t r l P P A R γ 2 C t r l P P A R γ 2 C t r l P P A R γ 2 Western blot analyses of cell lysates and culture media of NIH-3T3 cells overexpressing V5-VSTM2A. Cells were plated the day before and culture medium was changed at time 0. Cells were lysed and culture medium was collected at the indicated time. S6K was used as a loading control. This experiment was performed once. (c) Immunoprecipitation of VSTM2A from culture media collected from 293T cells overexpressing a control protein or V5-VSTM2A. Immunoprecipitates were run on gel and a Coomassie staining was performed (left panel). To confirm the validity of the anti-VSTM2A antibody, a Western blot was performed on the V5-VSTM2A immunoprecipitate (right panel) (d) Deleting the peptide signal on VSTM2A impairs its secretion. Western blot analyses performed from cell lysates and culture media of 293T cells overexpressing VSTM2A or Δ-VSTM2A, which lacks a signal peptide. Cells were plated the day before and culture medium was changed at time 0. Cells were lysed and culture medium was collected at the indicated time. S6K was used as a loading control. The images are representative of five independent experiments. n.s. denotes a non-specific band. (e) Sequence alignment of VSTM2A protein between species. The yellow squares on the N residues highlight potential glycosylation residues. The red squares on C highlights cysteine residues potentially important for VSTM2A dimerization. lysates were collected at times 0h, 2h, 4h, 8h, and 24h for Western blot analyses.
Supernatant was centrifuged for 5 minutes to remove cell debris. Brefeldin A (Sigma, 00-4506-51) was added to the cells upon medium change to block protein secretion. Tunicamycin (Sigma, T7765) was added 6 hours prior to the medium change and kept in the medium until the end of the study. Lysates and supernatants of 293T cells overexpressing V5-VSTM2A were treated with PNGase F (NEB, P0704S) according to the manufacturer's procedure. Cells overexpressing a mutant form of VSTM2A with no signal peptide were processed as described above. To measure endogenous VSTM2A secretion, cells were allowed to grow to confluence (12-well plate) and medium was replaced with DMEM containing 10% FBS (0.5ml/well). Supernatant was collected after 24h, 48h or 72h and treated as described above. To measure the secretion of VSTM2A by adipose tissue, explants from P4 mice (n=4) were collected, washed in PBS and incubated at 37°C in 100 µl of DMEM containing 10% FBS. Samples of media were collected after 6 and 24 hours. Explants were also collected at the end of the experiments and Western blot analyses were performed.
Immunoprecipitation. Culture media samples (400 µl) were incubated for 1h on a rotor at 4°C with 4 µl of V5-tag antibody. Then 25 µl of washed beads (Protein G agarose, Pierce, 20398) were added and samples were further incubated overnight at 4°C on a rotor. The next day, the beads were washed, lysis buffer was added and protein extracts were boiled. Samples were run on gel and stained with Coomassie Blue. Bands were cut and analyzed by mass spectrometry. The protein extracts were also run on gel for Western blot analysis. Virus-containing supernatants were collected at 48 hours after transfection and filtered using a 0.45µ filter. Cells were infected for 24 hours in the presence of 8 µg/ml polybrene. After infection, the cells were dispersed into fresh medium. Cells were selected on the following days with 1 µg/ml puromycin. The vector used to overexpress VSTM2A was obtained from the CCSB Broad Lentiviral Expression
Collection (Plx304-VSTM2A-V5tag; CCSBBroad304_13431). The control protein used was acta2-V5tag (CCSBBroad304_00014). Viruses were produced as described above but the cells were selected with blasticidin (2.5µg/ml). Mouse VSTM2A and Δ-VSTM2A were cloned into MSCV (Addgene plasmid # 24828, a kind gift from Dr. Lin He). Overexpression of PPARγ2 was achieved using pBABE_PURO_PPARγ2 (Addgene plasmid #8853, a kind gift from Dr. Bruce Spiegelman, MIT) (Tontonoz et al., 1994) . Viruses were produced using gag/pol and CMV VSV-G as the packaging system and cells were infected and selected (puromycin) as described above.
Cloning. Primers were designed to amplify the coding sequence of mouse Vstm2a
by PCR (HotStarTaq DNA Polymerase, 203203). Specific restriction sites were included in primers. PCR products were first cloned into TOPO (Life science, 45-0641) and the preparation was next transformed in DH5alpha cells (Thermo Fisher Scientific, 18265017) . Plasmids were extracted from positive clones and digested with specific restriction enzymes. Digestion products were resolved on agarose gel.
Bands were extracted and an overnight ligation (T4 DNA ligase, NEB, M0202S) was performed with MSCV. This vector was used as a source to amplify and clone Δ-VSTM2A. The following primers were used.
